This Solicitation opportunity from Department Of Health And Human Services was posted on December 11, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Serological Assays for the Detection and Characterization of Influenza Viruses
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The solicitation numbered 75D30125R73235, issued by the CDC Office of Acquisition Services under the Department of Health and Human Services, seeks proposals for serological assays focused on the detection and characterization of influenza viruses. The procurement covers serology sample testing services, including base and optional tasks such as assay development, gap analysis, and surge support. The contract performance location is Atlanta, Georgia, with activities coordinated through the CDC’s Chamblee Campus. The solicitation process initially began in early 2025, with multiple amendments issued that extended deadlines, updated FAR clauses to reflect new Executive Orders, clarified technical requirements related to Phase I proficiency testing involving hemagglutination inhibition assay parameters, and suspended and subsequently reinstated procurement actions. Amendment 5, effective December 11, 2025, formally reopens the solicitation and resumes source selection activities following a prior suspension. It reinstates Jennifer Gartzke as the Contracting Officer point of contact while maintaining Vic Veguilla as the technical POC. This amendment incorporates responses to the Phase I evaluation from the Government and retains all other terms and conditions previously established. Proposal submissions are due by February 15, 2026. Throughout the solicitation, offerors are required to acknowledge receipt of amendments and comply with clarified submission instructions. While specific detailed contract clauses, pricing information, and evaluation factors are not provided in the available materials, the procurement emphasizes compliance with applicable FAR provisions and adherence to technical criteria related to sample testing accuracy, seroconversion benchmarks, and assay validation protocols outlined in previously issued Q&A documents. Inspection and acceptance responsibilities reside with the Government, with administration conducted out of Atlanta. The solicitation remains open for competitive offers targeting precise serological assay services critical to influenza virus surveillance and characterization efforts.
General Info
Place of Performance
Atlanta, GA, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information.
More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
